A Study Evaluating the Effects of GLPG3667 Given as Oral Treatment for up to 24 Weeks in Adults With Dermatomyositis

Condition:   Dermatomyositis Interventions:   Drug: GLPG3667;   Drug: Placebo Sponsor:   Galapagos NV Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials